Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Cureus
|
August 13, 2020
Third-Degree Atrioventricular Block as the Initial Presentation of Lyme Disease
Sana Riaz, Alisha Garel, Abinash Subedi, et al.
Journal of Investigative Medicine High Impact Case Reports
|
March 25, 2021
A Significant Pericardial Effusion Leading to Bronchial Compression: A Case Report
Suman Rao, Oluwateniola Olatunde, Akhila Sunkara, et al.
Journal of the American Medical Directors Association
|
May 6, 2005
Antimicrobial use in post-acute care: a retrospective descriptive analysis in seven long-term care facilities in Georgia
Chesley L Richards, Mounir Darradji, Andrew Weinberg, et al.
Investigative Ophthalmology & Visual Science
|
September 28, 2011
Activation of OX40 prolongs and exacerbates autoimmune experimental uveitis
Xiumei Wu, James T Rosenbaum, Grazyna Adamus, et al.
Biomedicines
|
August 28, 2025
SGLT2 Inhibitors and GLP-1 Receptor Agonists in Cardiovascular-Kidney-Metabolic Syndrome
Aryan Gajjar, Arvind Kumar Raju, Amani Gajjar, et al.
The American Journal of Pathology
|
October 19, 2010
Activation of OX40 augments Th17 cytokine expression and antigen-specific uveitis
Zili Zhang, Wenwei Zhong, David Hinrichs, et al.
Clinical & Translational Immunology
|
May 20, 2016
OX40, PD-1 and CTLA-4 are selectively expressed on tumor-infiltrating T cells in head and neck cancer
Ryan Montler, R Bryan Bell, Colin Thalhofer, et al.
Journal of Arrhythmia
|
December 17, 2025
Association Between Glucagon-Like Peptide-1 Receptor Agonists and Risk of Arrhythmias
Vikash Jaiswal, Muhammad Hanif, Aman Goyal, et al.
Journal of Autoimmunity
|
September 11, 2007
Species-specific immune responses generated by histidyl-tRNA synthetase immunization are associated with muscle and lung inflammation
Yasuhiro Katsumata, William M Ridgway, Timothy Oriss, et al.
Molecular Cancer Therapeutics
|
March 17, 2018
Potent Immune Modulation by MEDI6383, an Engineered Human OX40 Ligand IgG4P Fc Fusion Protein
Michael D Oberst, Catherine Augé, Chad Morris, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Cureus
|
August 13, 2020
Third-Degree Atrioventricular Block as the Initial Presentation of Lyme Disease
Sana Riaz, Alisha Garel, Abinash Subedi, et al.
Journal of Investigative Medicine High Impact Case Reports
|
March 25, 2021
A Significant Pericardial Effusion Leading to Bronchial Compression: A Case Report
Suman Rao, Oluwateniola Olatunde, Akhila Sunkara, et al.
Journal of the American Medical Directors Association
|
May 6, 2005
Antimicrobial use in post-acute care: a retrospective descriptive analysis in seven long-term care facilities in Georgia
Chesley L Richards, Mounir Darradji, Andrew Weinberg, et al.
Investigative Ophthalmology & Visual Science
|
September 28, 2011
Activation of OX40 prolongs and exacerbates autoimmune experimental uveitis
Xiumei Wu, James T Rosenbaum, Grazyna Adamus, et al.
Biomedicines
|
August 28, 2025
SGLT2 Inhibitors and GLP-1 Receptor Agonists in Cardiovascular-Kidney-Metabolic Syndrome
Aryan Gajjar, Arvind Kumar Raju, Amani Gajjar, et al.
The American Journal of Pathology
|
October 19, 2010
Activation of OX40 augments Th17 cytokine expression and antigen-specific uveitis
Zili Zhang, Wenwei Zhong, David Hinrichs, et al.
Clinical & Translational Immunology
|
May 20, 2016
OX40, PD-1 and CTLA-4 are selectively expressed on tumor-infiltrating T cells in head and neck cancer
Ryan Montler, R Bryan Bell, Colin Thalhofer, et al.
Journal of Arrhythmia
|
December 17, 2025
Association Between Glucagon-Like Peptide-1 Receptor Agonists and Risk of Arrhythmias
Vikash Jaiswal, Muhammad Hanif, Aman Goyal, et al.
Journal of Autoimmunity
|
September 11, 2007
Species-specific immune responses generated by histidyl-tRNA synthetase immunization are associated with muscle and lung inflammation
Yasuhiro Katsumata, William M Ridgway, Timothy Oriss, et al.
Molecular Cancer Therapeutics
|
March 17, 2018
Potent Immune Modulation by MEDI6383, an Engineered Human OX40 Ligand IgG4P Fc Fusion Protein
Michael D Oberst, Catherine Augé, Chad Morris, et al.
Page
of 1